The Journal of the National Cancer Institute has fired off another salvo in their competition-driven war on dietary supplements, publishing a flimsy study that somehow arrives at the conclusion that omega 3 fatty acids increase the risk for prostate cancer. This latest example of scientists for hire massages skimpy data to reach their faulty conclusion – which was quickly trumpeted by the Big pharma-sponsored media.

Consumers should understand that the 50 billion dollar per year cancer industry is seen as one of the fastest growing markets for incredibly toxic biological drugs. Cancer treatment is big business, both for the medical profession and pharmaceutical industry. It is “too big to fail” and requires bogus propaganda to perpetuate its monopoly of the marketplace.

Enter dietary supplements, wherein numerous supplements have proven non-toxic and potent anti-cancer mechanisms of operation, including DHA the fish oil. It is not that any supplement is a one-hit cure for cancer. Rather, supplements as part of a nutritional team along with proper diet, exercise, and lifestyle offer the best chances for any person not to get one of the diseases of aging.

In comparison, doctors and their drugs are needlessly killing at least 200,000 people per year, with one of the most deadly places on earth being the intensive care units of hospitals that rampantly spread antibiotic resistant infections.

It is the current dream of the cancer industry to keep people on ridiculously priced biological drugs that do not cure cancer but keep them alive, while they bilk the individual, their family, insurance, and taxpayers for billions of dollars. It is a major financial scam operating under the guise of trying to help people in difficult health situations.

The study in question proves nothing. It is looking at a data set of men that were in a vitamin E and selenium study. It is relying on measurements of fatty acids between those with prostate cancer and those without that it is essentially meaningless. For example, the study uses plasma amounts of fatty acids, which fluctuate readily with the last meal consumed. A good study would use the red blood cell level of fatty acids that are an accurate indicator of actual omega 3 consumption in the past 4-6 weeks. There is no knowledge of the dietary intake or the supplement intake of omega 3 for any participant (yet the researchers try to blame supplements).

The difference in the plasma fatty acid levels in the prostate cancer group versus the non-prostate cancer group was .2 percent, virtually nothing. Extrapolating data from such a meaningless starting point is irrelevant. As is ignoring an overwhelming body of science on the health benefits of essential fatty acids.

The actual headline of this study should be that “smoking reduces the risk for prostate cancer.” The clearest association found in their data was that the more a man smoked the less risk for prostate cancer he had. Wow. Does anyone believe that?

There is no good for the public health when trash is published to prop up an industry that cannot stand on its own due to its lack of results for many people. There is no science in this study that shows any mechanism in terms of how DHA or other essential fatty acids could cause cancer. It is plain and simple scaremongering.

Here are links to two other articles released by the supplement industry in response to this bogus anti-omega 3 campaign.

*These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease.Note: the asterisk mark following a paragraph and linking to the above FDA disclaimer applies to any or all statements in that paragraph.